Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Angelo Gordon Raises $1bn for Asset Based Specialty Private Credit Opportunities
Angelo Gordon, a $73bn alternative investment firm focused on credit and real estate investing, today announced the final close of the AG Asset Based Credit Fund, L.P. (the “Fund”) with over $1bn of equity commitments, exceeding its $800m target. The Fund received...
Japan Chipmaker Rohm to Invest $722M in Toshiba Buyout Fund Backed by Japan Industrial Partners
Japanese chipmaker Rohm said on Tuesday it will invest 100 billion yen ($722 million) in a fund backed by Japan Industrial Partners (JIP), which is launching a tender offer for Toshiba Corp. Rohm also plans to underwrite 200 billion yen of non-voting preferred stock...
Buyout firm Thomas H. Lee Partners agrees $1.6bn deal for Standish Management
Private equity firm Thomas H. Lee Partners (THL) has agreed to acquire a majority stake in Standish Management in a deal that values the U.S.-based fund administrator at about $1.6bn, including debt, people familiar with the matter said. THL prevailed in an auction...




